In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

Hookworm affects more than 576 million people across the globe and contributes to an estimated 43 percent reduction in future wage earnings in areas where infected individuals reside.

Pages